Life Sciences відкриті
[search 0]
більше
Download the App!
show episodes
 
Artwork
 
Join Štěpán Hýsek as he hosts interviews about exciting research projects across various life sciences fields. 'SHowcase for life sciences' is a place where researchers themselves present findings of their cutting-edge research.
  continue reading
 
Artwork

1
Life Sciences 360

Harsh Thakkar

Unsubscribe
Unsubscribe
Щомісяця+
 
Life Sciences 360 is an interview show that educates anyone on challenges, trends, and insights in the life-sciences industry. Hosted by Harsh Thakkar, a life-sciences industry veteran and CEO and co-founder of Qualtivate, the show features subject-matter experts, business leaders, and key life-science partners contributing to bringing new therapies to patients worldwide. Harsh is passionate about advancements in life sciences and tech and is always eager to learn from his guests— making the ...
  continue reading
 
Artwork

1
Life Sciences D’n’A

Levine Media Group

Unsubscribe
Unsubscribe
Щодня+
 
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
  continue reading
 
Artwork
 
Students and scholars in life sciences need to use many skills to survive and excel during scientific training, which involves listening, reading, writing, and speaking. But I have seen many of them struggle in understanding and learning those skills. As a professor, I will guide you through the skills, so that you will learn and improve successfully in your professional life. Please visit my website for more information (https://synaptologica.com/), and send me emails with questions, commen ...
  continue reading
 
In this limited podcast series, we’ve brought together a series of conversations with experts from medical science to finance to help demystify investing in biotech, medtech and digital health (also known as the life sciences). This podcast has been brought to you by Life Sciences WA (Western Australia’s Life Sciences Industry Association) in collaboration with Talking HealthTech. It has been possible with funding support from the West Australian government through the New Industries Fund an ...
  continue reading
 
Leading Minds podcast by Life Sciences Voice, hosted by Jasmeet Sawhney, delves deep inside the minds of the top life sciences executives, including pharmaceuticals, biotech, medical devices, consumer health, animal health, and leaders from related industries. In every episode, we meet a leader who has made a lasting impact in the life sciences industry and continues to drive the industry forward. We go beyond the name and the title to unravel their personality, their beliefs, their mission, ...
  continue reading
 
Artwork

1
Being a Life Sciences Leader

Life Sciences Pennsylvania

Unsubscribe
Unsubscribe
Щомісяця
 
With a bird’s-eye-view of the life sciences industry, Life Sciences Pennsylvania President & CEO, Chris Molineaux, joins Rachael Bushey, Partner and Co-managing Partner of the Philadelphia office of Goodwin Procter to welcome life sciences leaders to give insights into the complex and high-risk world of pharmaceuticals, biotechnology, medical devices, diagnostics and the services that support them. Here we learn what it means to be a life sciences leader.
  continue reading
 
Invent: Life Sciences, is a podcast exploring the impact of biology and technology on the life sciences sector. Each week, we're joined by the top scientists, engineers, and academics working at the vanguard of this vital industry, to give you a behind-the-scenes look at the world of the life sciences.
  continue reading
 
BDO’s Health & Life Sciences Rx Podcast, hosted by The BDO Center for Healthcare Excellence & Innovation and the Life Sciences practice, seeks to provide insights into the trends disrupting healthcare and how companies can adapt and evolve in an ever-changing business landscape.
  continue reading
 
This is Politics & Life Sciences (PLS) Radio which is an interplay of Life Sciences and Politics. I am your host Dean L. Fanelli, Ph.D. I am an Intellectual Property attorney in Washington, DC. My practice focuses on issues attendant to the Life Sciences industry. On PLS, we will explores cutting edge topics involving the Biotech and Pharma ecosystems and looks at political or governmental policy issues affecting the Biotech and Pharma industries. Each week, PLS will have amazing guests incl ...
  continue reading
 
Artwork

1
Life Sciences in Queensland Podcast

Life Sciences Queensland

Unsubscribe
Unsubscribe
Щомісяця
 
Join us on this podcast series as we meet the icons of the biotechnology industry, exploring the current state of innovation in Queensland and what the future holds for our best and brightest. Hosted by Anthony Frangi, each episode will feature a new guest sharing their unique angle on the capabilities of the industry in Queensland.
  continue reading
 
Artwork

1
Image Movie Bachelor und Master in Life Sciences | Video

FHNW | HSL | Hochschule für Life Sciences-HSL

Unsubscribe
Unsubscribe
Щодня+
 
Life Sciences tönen nicht nur spannend, sondern sind es auch! Wir messen uns in Lehre und Forschung an internationalen Qualitätsstandards und fördern Transdisziplinarität sowie die Kooperation mit Netzwerken und vielfältigen Partnern. Unser Ziel ist es, den faszinierenden Life Sciences-Wissenschaften marktwirtschaftliche Anwendungen zu geben und gemeinsam mit Forschungspartnern ein international unverwechselbares Hochschulprofil zu etablieren. Im Zentrum unserer Aus- und Weiterbildung steht ...
  continue reading
 
Join Nancy Donohoo’s bi-weekly podcast, Talk at the Top, and get to know the key influencers in life sciences and healthcare who are positively impacting patients, providers, consumers and the industry itself! Nancy’s guests include groundbreakers and executives from across the healthcare spectrum: CEOs, physician executives, medical affairs and scientific leaders, venture capital and private equity investors, academics and entrepreneurs. This is your front row ticket to discussions on innov ...
  continue reading
 
Loading …
show series
 
In this episode Tuvik Beker, CEO of Pangea Biomed, sits down with Dr. Amar Drawid to discuss the evolution of precision medicine, the challenges in matching the right drugs to the right patient, and how Pangea uses AI to analyze expression data and gene interaction maps to select the most effective drugs for individual patients.…
  continue reading
 
Heather talks about the role of art in quality and documentation, challenges with document control methods, and her experience writing an article for Quality Magazine. She shares advice for entering the life sciences industry and the role of mentors in career development. Harsh and Heather also address the importance of mental health for leaders, t…
  continue reading
 
Dive deep into Step 11 of reading the milestone article written by Nobel Laureates. We will examine the most important bar graph. We will read the labels and the legend, and combine our knowledge with the Nobel Committee video. We will use the information flexibly to understand the story the graph tells. This is Part 8 of the reading mini-series "L…
  continue reading
 
Episode 034: Harsh Thakkar (@harshvthakkar) interviews Kimberly Wallbank (@kimberlywallbank), the Principal Consultant at Quality Systems Services, LLC. Kimberly addresses the evolution of quality and regulatory practices, particularly the increased focus on risk assessment. She discusses the challenges companies face with compliance and the need f…
  continue reading
 
Data analytics has evolved significantly in the pharmaceutical industry, providing sales professionals with better insights and decision-making capabilities. On this episode, Dr. Amar Drawid sits down with 40-year biopharmaceutical industry veteran Jonathan Blutfield, principal consultant with TriRadial Solutions, to discuss the evolution of data a…
  continue reading
 
Visual elements in scientific papers often convey information faster than words. In Part 7 of reading mini-series, we will discuss previewing the paper content by scanning the figures and tables. This step will help us gain a quick overview of Nobel Prize-winning research. (My email is active. But my website is under construction. Please wait for a…
  continue reading
 
Episode 033: Harsh Thakkar (@harshvthakkar) interviews Chijindu E. O. (@chijindu-authorceco), the Founder & Creative Director of Ceco Creations. Chijindu shares his journey in the field of science and art, starting with creating cartoons and animations to inspire and educate people, noting that visual appeal and creativity can make scientific conte…
  continue reading
 
Today, we are honored to have Gurdyal Kalsi as our guest, holding the position of Chief Medical Officer at Asklepion Pharma and AdventHealth and overseeing a varied Research and Development portfolio. Gurdyal explores the significance of AI in healthcare and emphasizes a long-overdue shift toward giving patients a voice in clinical trials. He under…
  continue reading
 
In this episode of the LSWA podcast, host Tracey Wilkinson interviews Fleta Solomon and Michael Winlo, two experts in the field of psychedelic-assisted therapy and medical cannabis. They discuss the potential of these treatments to revolutionise mental health care and provide a more holistic approach to patient care. The conversation begins with a …
  continue reading
 
In this episode of the LSWA podcast, host Tracey Wilkinson sits down with Natalie Barber, the director of Clinical Operations at Chrysalis Advisory, and Professor Peter Richmond from the University of Western Australia. Natalie and Peter discuss their respective roles in the clinical trial space. Peter, a paediatrician, focuses on improving childre…
  continue reading
 
Episode 032: Harsh Thakkar (@harshvthakkar) interviews Elizabeth Smalley (@elizabeth-smalley-product-leader), the Director of Product Management, Data and Analytics at Aris Global. Elizabeth discusses proactive safety signal detection in the context of drug development and the challenges faced in this space. She highlights the importance of utilizi…
  continue reading
 
In Part 6 of reading mini-series, we will discuss key steps before diving into a paper. We will verify the paper's identity and map its structure. These simple actions will give us a bird's-eye view of the paper and set us up for a deeper, rewarding reading experience. (My email is active. But my website is under construction. Please wait for a whi…
  continue reading
 
In this episode of the Investor Meets Innovator Podcast, host Peter Birch sits down with Paul Anderson, the Managing Director of Orthocell. With over 25 years of experience in the medical space and a background in device development and regenerative medicine, Paul shares his insights on the life sciences industry and the journey of bringing innovat…
  continue reading
 
Welcome to Part 5 of our mini-series on reading. Today, we will discuss a crucial step before diving into a paper. This powerful step will shift your focus from passively absorbing the written content to actively engaging with the authors' intent. By understanding what they are doing with each sentence and paragraph, you will gain a clearer overvie…
  continue reading
 
Episode 031: Harsh Thakkar (@harshvthakkar) interviews Penelope Przekop (@penelopeprzekop), the CEO at PDC Pharma Strategy and author of the book 'Five Star Career.' Penelope discusses her background in the pharmaceutical industry and the importance of quality management. She provides practical advice on collaboration, continuous learning, and find…
  continue reading
 
Episode 030: Harsh Thakkar (@harshvthakkar) interviews Ivan Perez Chamorro (@ivan-perez-chamorro) the CEO and Founder of MedBoard. Ivan shares the inspiration behind starting MedBoard. He recognized the need for a platform that provides access to trusted information in the life sciences industry. He describes how AI is integrated into MedBoard to a…
  continue reading
 
As the year comes to an end, Chris Molineaux and Rachael Bushey take the mike one final time to discuss the major themes and top lessons. From a year with no shortage of challenges, hear the four best approaches our guests utilize to lead their teams and work toward a stronger future for their organization.…
  continue reading
 
Tom Sellig, MBA, CEO of Adare Pharma Solutions, joins the podcast to discuss the importance of having a vision of collaboration and alignment within an organization. Learn more about Tom's journey in constructing a leadership team and discover key insights into effective decision-making practices.Life Sciences Pennsylvania
  continue reading
 
This episode is Part 4 of a multi-episode mini-series on reading. When we want to read a paper written by the Nobel Laureates, you might wonder which one to choose. We will discuss how to select the right paper from among the many that the Laureates have written. How do we do it? There's a simple way. (My email is active. But my website is under co…
  continue reading
 
In this episode of LSWA Investor Meets Innovator, Host Tracey Wilkinson talks with Simon Handford and Angela Fonceca about the challenges and complexities of tech transfer offices and taking research to commercialisation. They discuss the challenges of taking an innovation from academia and industry, the slow pace of negotiations, issues with fundi…
  continue reading
 
Episode 029: Harsh Thakkar (@harshvthakkar) interviews Bethany Corbin (@bethanycorbin), the Co-Founder of FEMInnovation and Managing Partner at Women's Health Innovation Consulting. Bethany shares her journey, going from law studies to founding FEM Innovation, focusing on improving reproductive health for women. She talks about the challenges women…
  continue reading
 
This episode is Part 3 of a multi-episode mini-series on reading. The biggest hurdle when we read a paper written by the Nobel Laureates is usually our lack of knowledge necessary to understand even the basics of the paper. We will talk about how to obtain the minimal amount of the most accurate background information. It is to watch a YouTube vide…
  continue reading
 
In this episode of the Investor Meets Innovator Podcast, host Peter Birch is joined by Ian Brown, Executive Chairman, and Intan Oldakowska, Chief Scientific Officer, of Rex Ortho. They discuss the journey of Rex Ortho, a platform technology company focused on orthopaedic fixations, particularly in proximal femoral fractures. Intan shares the backgr…
  continue reading
 
In this episode of the Investor Meets Innovator Podcast, host Peter Birch speaks with Arjun Balaji, an analyst with a clinical background at Tenmile, a venture capital firm in Perth, Western Australia. Arjun shares his background in medicine and his journey into the world of biotech startups before transitioning to investing. In this episode Arjun …
  continue reading
 
In this episode of the Investor Meets Innovator Podcast, host Peter Birch sits down with Dr Melissa McBurnie, Partner and Head of Impact at Brandon Capital. You will hear about how Brandon Capital approaches investing with impact in the life sciences and get some insights into the processes that they use when making an investment in this space. You…
  continue reading
 
Episode 028: Harsh Thakkar (@harshvthakkar) interviews Dr. Cortney Warren (@drcortney), a Clinical Psychologist and the Founder and Owner of Choose Honesty LLC. Dr. Cortney emphasizes the need for mindfulness regarding our technology usage and its effects on our mental health. She also delves into the importance of being truthful about our struggle…
  continue reading
 
Let's enjoy the Nobel Prize announcement. How do we enjoy it? We will read one paper written by the Nobel Laureates, and dive deep. This episode is Part 2 of a multi-episode mini-series on reading. We will talk about: 1) how the Nobel Prize laureates are selected, 2) what a milestone article is, 3) why we would want to read the milestone article by…
  continue reading
 
Throughout this series of Invent, we have brought you cutting-edge developments in the Life Sciences industry. We have spoken to a wide range of guests who have provided fascinating insights into the manufacture of cell and gene therapies, and what developments in drug testing mean for the future of genetic research. A big thank you to all our gues…
  continue reading
 
Randy Hubbell, MBA, former President & CEO of Carmell Corporation, joins the podcast to discuss the importance of humility and persevering as a leader in the life sciences industry. Learn more about Randy's experience in building a culture within a start-up company, his role in creating a new brand identity and how he led a successful transition to…
  continue reading
 
Let's enjoy the Nobel Prize announcement. How do we enjoy it? We will read one paper written by the Nobel Laureates, and dive deep. This episode is Part 1 of a multi-episode mini-series on reading. We will talk about two goals of reading the paper. (My email is active. But my website is under construction. Please wait for a while. Thank you for the…
  continue reading
 
Episode 027: Harsh Thakkar (@harshvthakkar) interviews Niyati Patel (@niyatipatel), the Director of Quality Engineering at Getinge (Maquet Cardiovascular) and a Sr. Regulatory/ Quality Consultant at Compliance Insight, Inc. Niyati breaks down the complexities of quality management systems, compliance, and regulations in the industry. She discusses …
  continue reading
 
Throughout this series, we’ve explored different diseases we target, the sorts of cells which are under development as therapies, and how the therapies themselves are manufactured. With all this innovation, we shouldn’t be surprised by the increased focus on the means by which processes and products themselves are characterised. So, do current proc…
  continue reading
 
Across the life sciences industry, there is much excitement over the potential impact of stem cells in medicine. And it is clear why; these cells, which can be differentiated into any other cell type, could rewrite the playbook in terms of sourcing cellular material for advanced therapies manufacture. So how might therapy developers benefit from th…
  continue reading
 
Pete DiBattiste, M.D., President & CEO of Prolocor, joins the podcast to discuss his journey from practicing medicine to pursuing the life sciences industry and the transition from large pharma to a start-up company. Pete emphasizes the importance of building a network and the abundance of scientific advancements inside and outside the walls of big…
  continue reading
 
Episode 026: Harsh Thakkar (@harshvthakkar) interviews John McKay (@johnlmckay), President, Chief Operating, Quality & Regulatory Affairs Officer at Q1 Associates LLC. John emphasizes the critical role of quality plans in ensuring error prevention and maintaining top-notch quality in the life sciences industry. The conversation takes a global persp…
  continue reading
 
Throughout almost all of medical history, it was assumed that the average white male response to drug trials could be extrapolated to all potential recipients. But when we look at the poorer health outcomes for women and minorities, could the underlying assumptions in medical research be a contributing factor? If so, what is being done to solve the…
  continue reading
 
Pharmaceutical companies undertake rigorous clinical trials in order to find out which drugs are safe. But in order to better protect the people volunteering for these tests, regulators decreed that data from studies on animals would be the primary evidence needed before approving a clinical trial in humans. Testing drugs on animals has many ethica…
  continue reading
 
Episode 025: Harsh Thakkar (@harshvthakkar) interviews Kamya Elawadhi (@kamya_elawadhi), SVP of Platform and Corporate Strategy at Doceree. Kamya shares her wealth of experience in healthcare advertising and innovation, bridging the challenges and opportunities of navigating regulatory environments and leading in the healthcare advertising industry…
  continue reading
 
Modern medicine has helped us develop many effective treatments for diseases found throughout the body, but we’ve yet to have the same success with the brain. The so-called 'blood brain barrier' controls the passage of molecules out of the blood and into the brain, and so it’s not as easy to use the bloodstream to carry therapeutic molecules as we …
  continue reading
 
Al Gianchetti, President & CEO of XyloCor Therapeutics joins Chris and Rachael to discuss how more than 20 years in large pharma brought him to the opportunity of becoming the CEO of a biotech start-up. Learn Al's perspective on selecting the right team and how he has built his leadership traits over time.…
  continue reading
 
In the pharmaceutical industry, there is a desire to go beyond the traditional ‘compound x acts on protein y,’ and achieve a more nuanced effect on the underlying biology. So, could innovative approaches to small molecules open up a wider application space? And what benefits might this bring to cash-strapped healthcare systems? To find out, join us…
  continue reading
 
Episode 024: Harsh Thakkar (@harshvthakkar) engages in a riveting discussion with RJ Kedziora (@RJKedziora), Co-Founder / Partner and Solutions Architect Estenda Solutions, Inc. In this episode, RJ uncovers the ins and outs of blending clinical information with imaging data, especially for patients with chronic conditions like diabetes and hyperten…
  continue reading
 
Cell and gene therapies are extremely effective but their complex production processes, arduous supply chain, and life-critical logistics have prevented mass market adoption. Could digitisation and AI provide a breakthrough in manufacturing? Would more companies be willing to work together on standardisation to provide more flexibility? To find out…
  continue reading
 
Today, we have the privilege of hosting Ramona Sequeira, the President of Takeda's Global Portfolio Division. She will delve into Takeda's involvement in the Life Science sector, shedding light on leadership, employee oversight, and recruitment. Ramona emphasizes three essential qualities for those aspiring to join her team: curiosity, humility, an…
  continue reading
 
The Covid vaccination campaign demonstrated the effectiveness of mRNA-based treatments, so what else is this technology capable of? How can we improve our manufacturing and distribution to ensure treatments are available to those who need them most? To find out, join us on Invent: Life Sciences, a podcast brought to you by technology and product de…
  continue reading
 
Loading …

Короткий довідник